The co-occurrence of obesity with cancer-related fatigue and their impact on physical function among breast cancer survivors
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Purpose To evaluate the associations of obesity and cancer-related fatigue (CRF) among breast cancer survivors, and the impact of their co-occurrence on physical function.Methods In a nationwide randomized clinical trial, we assessed body mass index (BMI; kg/m2), CRF via the Brief Fatigue Inventory (BFI), and physical function via hand grip dynamometry (muscular) and 6-minute walk test (cardiorespiratory) among breast cancer survivors at baseline.Results Among 456 participants with a breast cancer diagnosis (stage I–IIIC, mean age 55.9 years, 23.5 months post first-treatment, 86% white), 43.9% have obesity (BMI ≥ 30 kg/m2), and 32.7% have overweight (BMI 25–29.9 kg/m2). Compared to those with a normal weight, survivors with obesity are more than twice as likely to experience moderate-severe CRF (BFI total score ≥ 4; OR [95%CI] = 2.21 [1.35–3.63]). Survivors with co-occurring overweight/obesity and moderate-severe CRF have significantly worse cardiorespiratory function than those with either condition alone.Discussion Overweight/obesity and CRF are highly prevalent among breast cancer survivors. Survivors with obesity experience worse CRF compared to those with normal weight. Survivors with co-occurring overweight/obesity and severe CRF experience worse cardiorespiratory function, and this persists post-diagnosis. Given the long-term detrimental impact of these conditions on QOL and survival, these findings underscore the need for targeted interventions.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- The co-occurrence of obesity with cancer-related fatigue and their impact on physical function among breast cancer survivors
- Date Crossref
- 08/05/2026
- Éditeur
- Informa UK Limited
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.